These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10254499)

  • 21. [Incidence of isolation and antibiotic resistance of E. coli responsible for urinary infections outside hospitals, in specialized hospitals and in general hospitals].
    Lionsquy G; Delaitre E; Pin P; Bourlioux P; Bourlioux N
    Pathol Biol (Paris); 1984 May; 32(5):389-92. PubMed ID: 6377207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan.
    Hsueh PR; Ko WC; Wu JJ; Lu JJ; Wang FD; Wu HY; Wu TL; Teng LJ
    J Microbiol Immunol Infect; 2010 Oct; 43(5):452-5. PubMed ID: 21075714
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacterial drug resistance in the community and in hospitals.
    Degener JE; Michel MF; Valkenburg HA; Smit AC; Muller L; Thonus IP
    Neth J Med; 1985; 28(5):182-91. PubMed ID: 4010835
    [No Abstract]   [Full Text] [Related]  

  • 24. Update of systemic antimicrobials: emphasis on oral agents.
    Allen DM; Ling ML
    Singapore Med J; 1994 Dec; 35(6):626-30. PubMed ID: 7761891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The limitation of antibiotic use in hospitals.
    Williams JD
    Prog Clin Biol Res; 1979; 35():1-7. PubMed ID: 538023
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibiograms by the diffusion method. Basic concepts and evaluation of various current systems].
    Vandepitte J
    Acta Clin Belg Suppl; 1971; 7():3-22. PubMed ID: 4948539
    [No Abstract]   [Full Text] [Related]  

  • 27. The indiscriminate use of antimicrobials.
    Sumner-Smith G
    Vet Comp Orthop Traumatol; 2008; 21(1):I. PubMed ID: 18288337
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical results and costs due to improved antibiotics policies].
    Gyssens IC; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratories and regulator misled over antibiotic susceptibility test discs: patients may have received inappropriate antibiotic treatment as a result of quality problems withone company’s test discs, Deborah Cohen and Glenn Swift report.
    Cohen D; Swift G
    BMJ; 2013 Feb; 346():f837. PubMed ID: 23403982
    [No Abstract]   [Full Text] [Related]  

  • 30. Emergency of antibiotic resistance needs to be prevented, controlled,
    Cohen M
    Hosp Infect Control; 1982 Aug; 9(8):109-11. PubMed ID: 10257429
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antibiotic policy].
    Cobo Elosua M
    Rev Med Univ Navarra; 1976; 20():135-41. PubMed ID: 1019493
    [No Abstract]   [Full Text] [Related]  

  • 32. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.
    Fridkin SK; Steward CD; Edwards JR; Pryor ER; McGowan JE; Archibald LK; Gaynes RP; Tenover FC
    Clin Infect Dis; 1999 Aug; 29(2):245-52. PubMed ID: 10476720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing incidence of resistance to antimicrobials in Sidamo.
    Belihu A; Lindtjorn B
    Ethiop Med J; 1999 Jul; 37(3):181-7. PubMed ID: 11957315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [European requirements in microbiological evaluation of antibiotics].
    Soussy CJ
    Med Mal Infect; 2008 Dec; 38(12):623-4. PubMed ID: 18995975
    [No Abstract]   [Full Text] [Related]  

  • 35. Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.
    Counts JM; Astles JR; Tenover FC; Hindler J
    J Clin Microbiol; 2007 Jul; 45(7):2230-4. PubMed ID: 17522281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gorillacillins.
    Grossmann J
    Health (N Y); 1983 Sep; 15(9):33-8. PubMed ID: 10289497
    [No Abstract]   [Full Text] [Related]  

  • 37. [Orbicin, a new aminoglycoside antibiotic. Clinical experiences].
    Henneke H; Schmiedel A
    MMW Munch Med Wochenschr; 1979 Nov; 121(45):1505-6. PubMed ID: 117333
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial resistance: dentistry's role.
    Haas DA; Epstein JB; Eggert FM
    J Can Dent Assoc; 1998; 64(7):496-502. PubMed ID: 9737080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is it possible to rationalize antibiotic usage in hospitals?].
    Ribas J; Trilla A
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):577-80. PubMed ID: 8808472
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobials in children and the problem of drug resistance.
    Aronoff SC
    Am Fam Physician; 1996 Jul; 54(1):44-6, 54, 56. PubMed ID: 8677849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.